Volume 9 Supplement 2

15th Scientific Symposium of the Austrian Pharmacological Society (APHAR)

Open Access

Bioavailability of dodeca-2E, 4E, 8E, 10E/Z-tetraenoic acid isobutylamides after oral administration in rats and distribution in various tissues

  • Karin Wölkart1,
  • Reginald Frye2,
  • Hartmut Derendorf3,
  • Veronika Butterweck3 and
  • Rudolf Bauer1Email author
BMC Pharmacology20099(Suppl 2):A35

https://doi.org/10.1186/1471-2210-9-S2-A35

Published: 12 November 2009

Background

Preparations from Echinacea are among the best-selling phytopharmaceuticals worldwide and have been widely used for the treatment of common cold and various upper respiratory infections. The most relevant active principles of Echinacea extracts are alkamides, caffeic acid derivatives (CADs) and glycoproteins/polysaccharides [1]. The main alkamides in Echinacea preparations are the isomeric dodeca-2E,4E,8E,10E/Z-tetraenoic acid isobutylamides (''tetraenes''). Until now, a limited number of pharmacokinetic studies with alkamides have been reported, but no data exist about their distribution in tissues and transport through the blood-brain barrier (BBB). Therefore, we evaluated the pharmacokinetics of dodeca-2E,4E,8E,10E/Z-tetraenoic acid isobutylamides after a single oral dose administration of 2.5 mg/kg in plasma as well as in liver and four different brain regions (hippocampus, cerebral cortex, striatum and cerebellum).

Methods

Plasma and tissues were collected after 8, 15, 30 minutes and 1, 2, 3, and 6 hours after oral dosing and the concentrations were determined by a liquid chromatography tandem mass spectrometry (LC-MS/MS) method with benzanilide as internal standard using the respective [M-H]+ ions, m/z 248/152 for the dodeca-2E,4E,8E,10E/Z-tetraenoic acid isobutylamides and m/z 198/105 for the internal standard.

Results

The liphophilic constituents were rapidly absorbed and well distributed to the examined tissues. The highest concentration was found in the striatum. The total tetraene amount in plasma was calculated as AUC0-∞ (794 min·ng/mL), which was about 13-45% of that found in different brain parts (1764-6192 min·ng/mL), and 63% of that in liver tissues (1254 min·ng/g). The Cmax in plasma was 26.4 ng/mL, while the Cmax in the different brain regions varied between 33.8 ng/g and 46.0 ng/g.

Conclusion

The results demonstrate that the dodeca-2E,4E,8E,10E/Z-tetraenoic acid isobutylamides are bioavailable in rats with a rapid passage across the blood-brain barrier.

Declarations

Acknowledgements

Supported by the Erwin-Schrödinger scholarship (FWF) J2754-B05.

Authors’ Affiliations

(1)
Institute of Pharmaceutical Sciences, Department of Pharmacognosy, Karl Franzens University Graz
(2)
Department of Pharmacy Practice, College of Pharmacy, University of Florida
(3)
Department of Pharmaceutics, College of Pharmacy, University of Florida

References

  1. Bauer R: Chemistry, analysis and immunological investigations of Echinacea phytopharmaceuticals. Immunomodulatory Agents from Plants. Edited by: Wagner H. 1999, Basel, Boston, Berlin: Birkhäuser, 41-88.View ArticleGoogle Scholar
  2. Woelkart K, Frye RF, Derendorf H, Bauer R, Butterweck V: Pharmacokinetics and tissue distribution of dodeca-2E, 4E,8E,10E/Z-tetraenoic acid isobutylamides after oral administration in rats. Planta Med. 2009,Google Scholar

Copyright

© Wölkart et al; licensee BioMed Central Ltd. 2009

This article is published under license to BioMed Central Ltd.

Advertisement